ImproVue (Oculus Surgical, Inc.)
Welcome to the PulseAid listing for the ImproVue drug offered from Oculus Surgical, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Oculus Surgical, Inc. |
NON-PROPRIETARY NAME: | HYPROMELLOSE 2208 (15000 MPA.S) |
SUBSTANCE NAME: | HYPROMELLOSE 2208 (15000 MPA.S) |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2014-06-25 |
END MARKETING DATE: | 0000-00-00 |
ImproVue HUMAN OTC DRUG Details:
Item Description | ImproVue from Oculus Surgical, Inc. |
LABELER NAME: | Oculus Surgical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 17(mg/mL) |
START MARKETING DATE: | 2014-06-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62144-5510_2b072821-c4b6-4267-a6b1-844536e0b7e8 |
PRODUCT NDC: | 62144-5510 |
APPLICATION NUMBER: | part349 |
Other HYPROMELLOSE 2208 (15000 MPA.S) Pharmaceutical Manufacturers / Labelers: